Delineating thrombus versus myxoma: Perioperative 3D transesophageal echocardiography to the rescue!

Mohanish Badge1, Poonam Malhotra Kapoor1, T Thiruselvan1

  • 1Department of Cardiac Anaesthesia and Critical Care, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Insights

Diagnosing cardiac masses like myxomas can be challenging. Advanced 3D echocardiography offers superior imaging to differentiate tumors from blood clots, improving patient care.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Diagnostic Technology

Background:

  • Cardiac masses pose significant risks, impacting patient morbidity and mortality.
  • Accurate preoperative diagnosis is crucial for effective treatment planning.
  • Transthoracic echocardiography is the primary diagnostic tool for cardiac masses.

Observation:

  • Myxomas, the most common benign cardiac tumors, typically arise in the left atrium.
  • Atypical locations and morphologies of cardiac masses can create diagnostic challenges for 2D echocardiography.
  • Distinguishing cardiac myxomas from thrombi is critical for patient management.

Findings:

  • 3D echocardiography provides enhanced visualization capabilities compared to 2D echocardiography.
  • Multiplanar cropping and superior image quality aid in detailed cardiac mass assessment.
  • 3D echocardiography effectively differentiates cardiac myxomas from intracardiac thrombi.

Implications:

  • Improved diagnostic accuracy for cardiac masses, particularly myxomas.
  • Enhanced ability to distinguish benign tumors from potentially dangerous blood clots.
  • Potential to guide surgical planning and improve patient outcomes through precise preoperative imaging.